Observations on thyroid hormones in the blood of thoroughbreds

Circulating endocrine, metabolic, and haematologic indices during the peripartum period of Darehshori mares

The characteristics associated with equine peripartum period are different from those of other periods. Information concerning the values and dynamic changes of circulating peripartum endocrine, metabolic, and haematologic indices may improve the understanding of the whole body haemostatic patterns which lead to parturition, lactogenesis, and estrus in the horse. The present study aimed to evaluate these changes around parturition in Darehshori breed. For this purpose, blood sampling was performed on six clinically healthy Darehshori mares (10 years old) about one week prior to parturition, three days following parturition, at the beginning of estrus, and one week after estrus. Circula­ting values ​​of glucose, estrogen, progesterone, cortisol, T3, T4, TG, cholesterol, HDL, LDL, VLDL, RBC, HGB, HCT, MCV, MCH, MCHC, WBC, neutrophil, lymphocyte, and PLT were assessed in all samples. Progesterone concentrations were minimum before parturition and increased significantly one week after foaling heat (P=0.035). Cortisol level was significantly higher during foaling heat compared with other periods (P=0.029). T4 levels significantly increased from pre- to post-partum periods (P=0.001), but T3 showed increased and decreased values during the study period. All serum lipid profile parameters were significantly reduced from pre to postpartum period (P<0.05). Haematological parameters in mares significantly changed during the peripartum period (P<0.05). Based on the results, the metabolic, haematological, endocrinological, and stress indices in Darehshori mares were found to change around parturition and the first estrus. These changes were largely dependent on hormonal mechanisms related to pregnancy and parturition occurring in normal mares.

A randomised, controlled trial to determine the effect of levothyroxine on Standardbred racehorses

BACKGROUND

The use of thyroid supplement is pervasive in athletic horses although its effects on measures of performance are not known.

OBJECTIVES

One purpose of this study was to determine whether supra-physiologic doses of levothyroxine affect the velocities at which blood lactate was greater than 4 mmol/L (V_La4 ) and heart rate was over 150 (V₁₅₀ ) and 200 (V₂₀₀ ) beats per minute respectively. Additionally, a survey of post-race blood samples was also conducted to determine whether high thyroxine concentrations were common in racehorses.

STUDY DESIGN

A randomised, crossover, trial was performed in six healthy Standardbred racehorses.

METHODS

Study 1: T4 was determined in 50 post-race samples from a single Standardbred meet. Study 2: Research horses were trained to fitness and then randomised to one of three treatments: carrier, 0.1 mg/kg thyroxine or 0.25 mg/kg thyroxine for 2 weeks. Horses completed a standardised exercise treadmill test (SET) to fatigue on the last day of treatment. Serum free and total thyroxine and triiodothyronine were determined on the day of SET testing. Blood lactate and ECG data were collected during the SET at 6, 8, 10, 11, and 12 m/s and during recovery. The effect of treatment and SET on heart rate and blood lactate was examined using generalised linear mixed models. Post hoc analysis was adjusted for multiple comparisons using Tukey's Test. Data were expressed as mean ± standard deviation and P < .05 was considered significant.

RESULTS

Study 1: The median T4 value in this population of horses was 2.00 µg/dL (laboratory's normal range 1.5-4.5 µg/dL) and 3 of 50 racehorses had values above the laboratory reference range. Study 2: Levothyroxine at 0.25 mg/kg resulted in higher heart rates during SET (199 ± 30, 223 ± 17 and 239 ± 9 bpm at 6, 8 and 10 m/s respectively) and recovery (144 ± 20 and 119 ± 15 at 5 and 15 min) as compared to placebo (176 ± 18, 203 ± 10 and 219 ± 6 bpm at 6, 8, and10 m/s and 126 ± 5, 102 ± 11 at 5-15 minutes respectively). Three of six horses developed cardiac arrhythmias including atrial fibrillation.

MAIN LIMITATIONS

A relatively small number of animals were used and a SET is not identical to actual racing conditions.

CONCLUSIONS

Supra-physiologic thyroxine supplementation caused a decreased V₂₀₀ during a standard exercise test and may result in cardiac arrhythmias.

Duration of effects of phenylbutazone on serum total thyroxine and free thyroxine concentrations in horses

The objectives of this study were to determine if phenylbutazone decreased serum thyroxine (TT4) and free thyroxine (FT4) concentrations using radioimmunoassay and equilibrium dialysis techniques in horses, and, if so, an additional objective was to determine the duration of this decreased concentration once phenylbutazone administration was discontinued. Serum TT4 and FT4 concentrations were determined before and after administration of 4.4 mg/kg of phenylbutazone i.v. bid for 5 days. Treatment with phenylbutazone caused a significant decrease in TT4 and FT4 concentrations (P < .05). Serum TT4 concentration significantly decreased after day 4 of treatment and remained significantly below baseline value for 10 days after discontinuing phenylbutazone administration; it returned to a value not different from the baseline value by the 11th day. Serum FT4 concentration significantly decreased after day 4 of treatment and remained significantly below the baseline value for only 1 day after phenylbutazone administration was discontinued; it returned to a value not different from the baseline value by the 3rd day after discontinuation of phenylbutazone. These results indicate that serum TT4 and FT4 should not be used to evaluate thyroid function in horses receiving phenylbutazone. In addition, results should be interpreted cautiously when phenylbutazone has been administered within 2 days (for FT4) or within 10 days (for TT4) of sample collection.

Evaluation of endocrine function

This article outlines strategies on how to approach equine endocrine disorders based on clinical signs and clinical pathologic data. In the 1987 Veterinary Clinics of North America: Equine Practice article on evaluating equine endocrine function, Beech stated that the numbers of hormonal assays available to use in horses was limited. Unfortunately, not much has changed since then. With the advent of convenient assay kits for many hormones and cofactors available in human medicine, it is possible to submit samples to laboratories for measurement of a wide range of endogenous substances. Caution must be used when interpreting the results in equine patients. Assay kits that have not been validated for use in horses may yield results that have no clinical meaning. Using veterinary endocrinology laboratories with equine experience is the best way to assure meaningful results from diagnostic testing (Table 1). If this is not possible, submitting age, breed, and sex-matched controls along with samples from the patient horse will provide some measure of a reference range. Normal values or reference ranges from species other than the horse cannot be used to interpret the results of equine samples.

Equine thyroid function tests: a preliminary investigation

A similar and significant (P less than 0.001) increase in plasma thyroxine (T4) concentration was seen in seven clinically normal thoroughbred horses 2 h after the intravenous administration of either 2.5 iu or 5 iu of thyroid stimulating hormone (TSH) with a peak response around 4 h after administration. The intravenous administration of 0.2, 0.5 or 1 mg thyrotrophin releasing hormone (TRH) resulted in a significant (P less than 0.01) increase in T4 concentration in three groups of animals; six thoroughbreds in full work, five thoroughbreds at rest and four ponies at rest. The peak response was recorded at 3 or 4 h after administration. A significant difference between the groups in the degree of response to TRH was only found between the thoroughbreds in work and those at rest with 1 mg TRH (P less than 0.05). When two additional ponies were investigated in a similar way, a reduced response to TRH was observed: a pregnant mare had a similar response to 5 iu TSH as the thoroughbreds; the other pony also showed a lowered response to TSH. In a group of 2- or 3-year-old thoroughbreds in training no difference in the T4 response 4 h after intravenous administration of 0.5 mg TRH could be determined, according to the month, age, sex or work intensity. Although resting T4 concentrations did not differ significantly between animals believed to be suffering from the equine rhabdomyolysis syndrome (ERS) and those suffering from a variety of other conditions, some ERS sufferers may have a lowered response to TRH.